Makerere University
- Country
- 🇺🇬Uganda
- Ownership
- Private
- Established
- 1922-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.makerere.ac.ug
Clinical Trials
154
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (132 trials with phase data)• Click on a phase to view related trials
Enhancing Comprehension of Consent in Patients With Psychotic Disorders
- Conditions
- Psychosis
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 60
- Registration Number
- NCT06975670
Multimodal Analgesia Utilization and Acute Postoperative Pain After Major Surgery At Mulago National Referral Hospital
- Conditions
- Pain
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 449
- Registration Number
- NCT06887153
- Locations
- 🇺🇬
Mulago National Referral Hospital, Kampala, Uganda
Peer Delivered HIV/Syphilis Self-Testing with Assisted Partner Notification Services
- Conditions
- HIVSyphilis
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 200
- Registration Number
- NCT06791928
- Locations
- 🇺🇬
Infectious Diseases Institute, Makerere University, Wakiso, Uganda
Use of Unmanned Air Vehicles (Medical Drones) to Overcome Geographical Barriers to Delivery of Anti-Retroviral Therapy and Biological Samples
- Conditions
- HIVViral Load
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 1086
- Registration Number
- NCT06678022
Development and Evaluation of an Information Management System and Communication System for Population-wide Point-of-care Infant Sickle Cell Disease Screening
- Conditions
- Sickle Cell Disease
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 24000
- Registration Number
- NCT06563440
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇬College of Health Sciences, Makerere University, Kampala, Uganda
- Prev
- 1
- 2
- 3
- 4
- 5
- 28
- Next
News
Mycovia Pharmaceuticals Initiates Phase 2 Trial of Oteseconazole for Cryptococcal Meningitis
Mycovia Pharmaceuticals has enrolled the first participant in the PLATFORM-CM Phase 2 trial evaluating oteseconazole for cryptococcal meningitis treatment.
USAID Funding Freeze Threatens HIV Treatment Programs Across Africa
The recent USAID stop-work order has halted critical HIV research and treatment programs in Nigeria and Uganda, affecting millions of patients who depend on aid-funded antiretroviral therapy.
Uganda Launches Groundbreaking First-Ever Ebola Sudan Vaccine Trial with WHO Support
Uganda's Ministry of Health and WHO have initiated the world's first randomized vaccine trial for Ebola Sudan virus, launching in record time just four days after outbreak confirmation.